InvestorsHub Logo
Followers 34
Posts 2990
Boards Moderated 0
Alias Born 02/27/2016

Re: Jonjones325 post# 454865

Sunday, 03/24/2024 11:50:14 AM

Sunday, March 24, 2024 11:50:14 AM

Post# of 458325
Maybe that rebuke of the Alz Asoc in the Journal of Alz Disease is a precursor to the release of our peer review.

Timing is ripe with everything that’s happening in MAB and regulator land.

I’ll use Missling’s favorite word. Intriguing

It’s intriguing to see the lecanemab launch failure.
The slowing of brain atrophy is intriguing.
The very nice correlations between everything we have done is quite intriguing.

Missling pisses me off too but the unfolding events are intriguing to say the least.

It’s a gift for people getting in at this level. The Blank Check Preferreds help keep the vultures at bay.

I vividly remember that full page colored mailing about that vote. On nice card stock.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News